G&S Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,267
| Closed | -$510K | – | 134 |
|
|
2024
Q4 | $510K | Buy |
1,267
+614
| +94% | +$247K | 0.21% | 98 |
|
|
2024
Q3 | $304K | Hold |
653
| – | – | 0.13% | 112 |
|
|
2024
Q2 | $321K | Sell |
653
-36
| -5% | -$17.7K | 0.14% | 106 |
|
|
2024
Q1 | $288K | Sell |
689
-8
| -1% | -$3.34K | 0.13% | 113 |
|
|
2023
Q4 | $284K | Sell |
697
-149
| -18% | -$60.6K | 0.13% | 103 |
|
|
2023
Q3 | $294K | Hold |
846
| – | – | 0.15% | 106 |
|
|
2023
Q2 | $298K | Sell |
846
-492
| -37% | -$173K | 0.14% | 108 |
|
|
2023
Q1 | $422K | Sell |
1,338
-69
| -5% | -$21.7K | 0.19% | 91 |
|
|
2022
Q4 | $406K | Buy |
+1,407
| New | +$406K | 0.18% | 90 |
|
|
2020
Q3 | – | Sell |
-1,063
| Closed | -$309K | – | 93 |
|
|
2020
Q2 | $309K | Buy |
+1,063
| New | +$309K | 0.28% | 56 |
|